Dáil Éireann Debate, Tuesday - 11 May 2021
745. Deputy Colm Burke asked the Minister for Health the cost of the review by a company (details supplied) of governance structures in relation to the HSE drug reimbursement process; and if he will make a statement on the matter. [23981/21]
View answer746. Deputy Colm Burke asked the Minister for Health the specific date his Department plans to complete its consideration of a review by a company (details supplied) of the HSE drug reimbursement process; and if he will make a statement on the matter. [23982/21]
View answerI propose to take Questions Nos. 745 and 746 together.
Following a tender by the Office of Government Procurement, Mazars conducted a review of the governance structures around the HSE's drug reimbursement process. This report was submitted to my Department in January 2020. The total amount paid to Mazars for producing this report was €86,123.86 including VAT.
The review made recommendations in respect of the HSE’s systems, structures, processes, governance arrangements and use of specialist resources in respect of the drug reimbursement process.
The report was under consideration by officials earlier last year, however the focus of the Department of Health changed to the immediate public health considerations of the COVID-19 pandemic and the preservation of life. This meant that this work stream was temporarily suspended to reallocate resources to support essential services.
My Department aims to complete its consideration of the report’s recommendations in the near future.
